Digital Diabetes Management Market Size
| Study Period | 2018 - 2028 |
| Market Size (2024) | USD 17.12 Billion |
| Market Size (2028) | USD 29.13 Billion |
| CAGR (2024 - 2028) | > 11.00 % |
| Fastest Growing Market | North America |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Digital Diabetes Management Market Analysis
The Digital Diabetes Management Market size is estimated at USD 17.12 billion in 2023, and is expected to reach USD 29.13 billion by 2028, growing at a CAGR of greater than 11% during the forecast period (2023-2028).
Patients with diabetes were at higher risk for hospitalizations and complications due to hyper- or hypoglycemia, metabolic comorbidities, and more severe illness from SARS-CoV-2 infection. The maintenance of euglycemia was important to decrease both morbidity and mortality in the hospital setting. According to experts, inpatient use of diabetes technology in patients with proper institutional protocols was safe and improved inpatient glycemic outcomes and reduced hypoglycemia. Such factors gave a boost to the market studied during the pandemic.
Diabetes care, including diet, exercise, and determination of insulin dose and timing, is largely dependent on patient self-management. Digital healthcare plays an important role in the management of diabetes by providing tools and resources to help people with diabetes monitor their blood glucose levels, track their medications and activities, make informed decisions about their diet and exercise, and receive personalized guidance and support. Multiple digital tools and apps have been developed to assist patients and healthcare providers, including electronic medical records, insulin pumps, sensors, glucometers, and other wearables.
Furthermore, in recent decades, many smartphone applications have been developed to facilitate lifestyle management to encourage patients to maintain proper lifestyles through technology-based behavioral therapy. For instance, a single platform automatically integrates various data and contains an artificial intelligence-based food recognition program that replaces the complex manual input of dietary information with a photograph of each meal and becomes an appropriate digital health care option for people with diabetes, such as a mobile health care platform, Auto-Chek Care, can be linked to a glucometer, a sphygmomanometer, a scale with bioelectrical impedance analysis and a watch-type pedometer through Bluetooth, allowing all of the data to be automatically collected on the platform for integrated analysis in a single smartphone application.
In November 2023, BeatO, India's digital health platform focusing on diabetes control and treatment, announced that it would be launching physical touchpoints by collaborating with leading doctors in several micro-markets. With the launch of five such clinics across Delhi/NCR, it will be covering cities across Uttar Pradesh, Madhya Pradesh, Rajasthan, Gujarat, and Odisha over the next 6 months. The digital diabetes clinic aims to incorporate all digital patient data and provide individual virtual or face-to-face visits. Digital diabetes care is evolving as a safe, effective, and cost-saving technology providing modest HbA1c reduction with improved patient satisfaction, thereby achieving improved glycemic control with less frequent and severe hypoglycemic episodes, enhancing the market prospects in the years to come.
Digital Diabetes Management Market Trends
Rising obesity and diabetes prevalence
The diabetes population globally is expected to rise by 1.9% during the forecast period.
The major factors attributing to the growth of the market studied are an increase in obesity among people and a rising prevalence rate of type-2 diabetes and heart diseases. People with more fat in their bodies are highly likely to be affected by diabetes. Hence, such patients are likely to take certain measures to prevent obesity through self-management. For instance, as per the World Obesity Atlas 2023, the estimates for global levels of overweight and obesity (BMI ≥25kg/m²) suggest that over 4 billion people may be affected by 2035. The prevalence of obesity (BMI ≥30kg/m²) alone is anticipated to rise to 24% of the population over the same period, affecting nearly 2 billion adults, children, and adolescents by 2035.
Additionally, according to the World Health Organization (WHO) May 2022 report on the European region, in the WHO European Region, over 60% of adults and 29% of boys and 27% of girls who are children are overweight or obese and also, as per the same report, overweight and obesity rank fourth among the risk factors for non-communicable diseases in the region, after high blood pressure, unhealthy eating, and cigarette use. Furthermore, according to the latest International Diabetes Federation report, it is estimated that the number of adults in the age group of 20-79 years across the world is projected to increase to 643 million by 2030. Hence, owing to the high burden of obesity and the increasing prevalence of risk factors for obesity are expected to fuel the market growth over the forecast period.
Furthermore, according to the International Diabetes Federation's latest estimates, the adult diabetes population is approximately 537 million, and this number is going to increase to 643 million in 2030. The rapidly increasing incidence and prevalence of diabetic patients and healthcare expenditure worldwide are indications of the increasing usage of digital diabetes management. In 2022, the WHO Global Diabetes Compact outlined five diabetes targets to reach by 2030, focused on addressing metabolic risks, access to medication, and diagnosis. The outlook for a healthy future is further marked by sustained progress in strategies designed to remediate diabetes through control of calorie intake, physical activity, and medication with the help of diabetes management platforms.
Therefore, due to increased prevalence and the factors above, the studied market is anticipated to witness growth over the analysis period.
The North American region is Expected to Witness Highest Growth Rate Over the Forecast Period
The North American region is expected to register a CAGR of more than 5.3% in the market during the forecast period.
According to Mordor Intelligence, the diabetes population in the North American region is expected to grow, registering a CAGR of about 2% during the forecast period. The National Diabetes Statistics Report 2022 by the Centers for Disease Control and Prevention estimated that more than 130 million adults are living with diabetes or prediabetes in the United States. The North American Continuous market is expected to grow owing to factors such as the easy availability of digital diabetes management devices, high awareness among consumers, and reimbursement policies.
Digital clinical decision support systems help in managing insulin therapy. Smart algorithms calculate the proper dose of insulin considering various factors such as a patient’s body weight, diabetes type, current insulin requirements, activity level, nutritional status, etc. Various established tools and devices, such as smart insulin pens, provide accurate administration of bolus doses, simplification of data relating to diabetes therapy, and improved assistance. Bluetooth connectivity enables automatic and immediate transmission of data from the pen to a medical smartphone application app.
Various new launches in the market are expected to drive the market studied over the forecast period. For instance, Better in July 2023 received FDA clearance for its first digital therapeutic. Dubbed AspyreRx, the digital tool offers cognitive behavioral therapy to help people manage type-2 diabetes. The therapeutic specifically aims to address the underlying factors that contribute to disease progression and achieve treatment outcomes beyond glucose management alone.
The aforementioned factors are set to boost market growth.
Digital Diabetes Management Industry Overview
The digital diabetes management market is semi-consolidated, with a few significant and generic players such as Medtronic, Tandem, and Ypsomed. The major players are working on innovations which is evident from the companies spending on research and developments to strengthen their market presence. Furthermore, key market players are focusing on adopting advanced technologies and introducing new products through collaborations, acquisitions, and government initiatives to offer diabetes patients better services.
Digital Diabetes Management Market Leaders
-
Abbott
-
F. Hoffmann-La Roche Ltd.
-
Insulet Corporation
-
Dexcom
-
Medtronic
*Disclaimer: Major Players sorted in no particular order
Digital Diabetes Management Market News
- March 2023: Becton Dickinson launched the BD Diabetes Care App for People living with diabetes, Caregivers, Diabetes Educators, and Physicians. The BD Diabetes Care App’s tools and curriculum-based content are designed to provide trusted information on various topics around diabetes management.
- February 2023: The University of Pretoria’s (UP) Diabetes Research Centre, in conjunction with health tech company Aviro Health, launched the Aviro Pocket Clinic app for diabetes, which allows for patient registration, guided clinic and home visits for insulin initiation for people with type-2 diabetes as well as lifestyle counseling, among other features.
Digital Diabetes Management Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Drivers
4.3 Restraints
4.4 Porter's Five Forces Analysis
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Consumers
4.4.3 Threat of New Entrants
4.4.4 Threat of Substitute Products and Services
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 Type
5.1.1 Wearable Devices
5.1.2 Handheld Devices
5.2 Product
5.2.1 Smart Glucose meters
5.2.2 Continuous Glucose Monitoring Systems
5.2.3 Smart Insulin Pens
5.2.4 Smart Insulin Pump
5.2.5 Apps
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Rest of North America
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 Spain
5.3.2.3 Italy
5.3.2.4 France
5.3.2.5 United Kingdom
5.3.2.6 Russia
5.3.2.7 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 Japan
5.3.3.2 China
5.3.3.3 Australia
5.3.3.4 India
5.3.3.5 South Korea
5.3.3.6 Malaysia
5.3.3.7 Indonesia
5.3.3.8 Thailand
5.3.3.9 Philippines
5.3.3.10 Vietnam
5.3.3.11 Rest of Asia-Pacific
5.3.4 Latin America
5.3.4.1 Brazil
5.3.4.2 Mexico
5.3.4.3 Rest of Latin America
5.3.5 Middle East and Africa
5.3.5.1 South Africa
5.3.5.2 Saudi Arabia
5.3.5.3 Oman
5.3.5.4 Egypt
5.3.5.5 Iran
5.3.5.6 Rest of Middle East and Africa
6. MARKET INDICATORS
6.1 Type-1 Diabetes population
6.2 Type-2 Diabetes population
7. COMPETITIVE LANDSCAPE
7.1 COMPANY PROFILES
7.1.1 Abbott
7.1.2 F. Hoffmann-La Roche Ltd.
7.1.3 Ascensia Diabetes Care
7.1.4 Becton Dickinson
7.1.5 Medtronic
7.1.6 Bayer AG
7.1.7 LifeScan, Inc.
7.1.8 Dexcom, Inc.
7.1.9 Sanofi
7.1.10 Insulet Corporation
7.1.11 B. Braun Melsungen AG
- *List Not Exhaustive
7.2 COMPANY SHARE ANALYSIS
8. MARKET OPPORTUNITIES AND FUTURE TRENDS
Digital Diabetes Management Industry Segmentation
Digital health management includes devices, services, and platforms that play an important role in the care of individuals with diabetes and simplify self-management.
The digital diabetes management market is segmented by type (wearable devices and handheld devices), product (smart glucose meters, continuous glucose monitoring systems, smart insulin pens, smart insulin pumps, apps), and geography (North America, Europe, Asia-Pacific, the Middle East and Africa, and Latin America).
The report offers the values (in USD) and volume (in units) for the above segments.
| Type | |
| Wearable Devices | |
| Handheld Devices |
| Product | |
| Smart Glucose meters | |
| Continuous Glucose Monitoring Systems | |
| Smart Insulin Pens | |
| Smart Insulin Pump | |
| Apps |
| Geography | |||||||||||||
| |||||||||||||
| |||||||||||||
| |||||||||||||
| |||||||||||||
|
Digital Diabetes Management Market Research FAQs
How big is the Digital Diabetes Management Market?
The Digital Diabetes Management Market size is expected to reach USD 17.12 billion in 2024 and grow at a CAGR of greater than 11% to reach USD 29.13 billion by 2028.
What is the current Digital Diabetes Management Market size?
In 2024, the Digital Diabetes Management Market size is expected to reach USD 17.12 billion.
Who are the key players in Digital Diabetes Management Market?
Abbott, F. Hoffmann-La Roche Ltd., Insulet Corporation, Dexcom and Medtronic are the major companies operating in the Digital Diabetes Management Market.
Which is the fastest growing region in Digital Diabetes Management Market?
North America is estimated to grow at the highest CAGR over the forecast period (2023-2028).
Which region has the biggest share in Digital Diabetes Management Market?
In 2023, the North America accounts for the largest market share in Digital Diabetes Management Market.
What years does this Digital Diabetes Management Market cover, and what was the market size in 2023?
In 2023, the Digital Diabetes Management Market size was estimated at USD 15.24 billion. The report covers the Digital Diabetes Management Market historical market size for years: 2018, 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Digital Diabetes Management Market size for years: 2024, 2025, 2026, 2027 and 2028.
Digital Diabetes Management Industry Report
Statistics for the 2024 Digital Diabetes Management market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Digital Diabetes Management analysis includes a market forecast outlook for 2024 to 2028 and historical overview. Get a sample of this industry analysis as a free report PDF download.
